Skip to main content

Table 2 Anthropometric and demographic data, risk factors, and medications of the sedentary (SG) and the concurrent aerobic and resistance training groups (CART)

From: Potential Effects on Cardiorespiratory and Metabolic Status After a Concurrent Strength and Endurance Training Program in Diabetes Patients — a Randomized Controlled Trial

Variables

SG (N = 20)

CART-G (N = 21)

P

Age (years)

52.1 ± 7.3

49.5 ± 6.1

0.21

Height (cm)

167 ± 0.1

169 ± 0.1

0.53

Weight (kg)

85 ± 18.6

82.2 ± 19.4

0.63

BMI (kg/m2)

30.4 ± 5.8

30.1 ± 5.4

0.28

Duration type 2 diabetes (years)

7.4 ± 5.8

5.7 ± 5.5

0.17

SBP rest (mmHg)

131.1 ± 16.5

129.7 ± 15.8

0.79

DBP rest (mmHg)

89.4 ± 8.0

92 ± 11.1

0.40

HR (bpm)

83 ± 12.5

85.5 ± 13.1

0.54

Risk factors % (n)

 Tabagism

0

0

 CAD family history

20 (4)

23.8 (5)

1.00

 Dyslipidemia

50 (10)

42.8 (9)

0.75

 Obesity

55 (11)

38 (8)

0.35

 SAH

60 (12)

47.6 (10)

0.53

Medications

 Hypoglycemiants % (n)

  Biguanides

95 (19)

85.7 (18)

0.60

 Sulfonylurea

45 (9)

47.6 (10)

1.00

 Antihypertensive

  ACE I inhibitors

15 (3)

14.3 (3)

1.00

  Renin inhibitors

  

1.00

  ARAII

25(5)

20 (4)

0.71

  Diuretics

5 (1)

9.5 (2)

0.60

 Hypolipemiant

  Estatins

15 (3)

19 (4)

1.00

  Fibrates

10 (2)

0.23

  1. Data are reported as means ± SD. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, CAD cardiovascular disease, SAH systemic arterial hypertension, ACE I angiotensin converting enzyme I inhibitor, ARAII angiotensin II receptor antagonists